IDXX

IDEXX LABORATORIES INC

Nasdaq· In Vitro & In Vivo Diagnostic Substances· Inc. DE· CIK 0000874716 Biotech & Drug Discovery

$561.25 −8.96 (−1.57%)

Oct 27 4:00 PM ET · prev $570.21

Market cap

$44.1B

Large cap

Consensus

Buy

67% Buy or better · 21 analysts

Median target

🔒 Subscribers only

Next earnings

Nov 2

in 6 days

1 year

−11.5%

from $634.36 · Oct 28

30 days

+6.1%

from $529.06

52-week range

$504.70–766.68

−27% from high · low Sep 11

Avg volume 20D

517.4K

shares / day

Short interest

1.93M

≈2.5% of shares · −0.6%

Days to cover

3.6

at average volume

Insider net

−$18.4M

0 buyers · 3 sellers · since Feb 26

New fund stakes

Q2 2026 13F · 1 exit

SecBot read BULLISH 3 reports · 90 days

Balance 0 bearish · 1 bullish · 2 neutral oldest → newest, height = score

Avg score

·High conf. 2/3 ·Next Earnings date, Nov 2, 2026

Strongest NEUTRAL Three asset managers added to IDXX positions in Q3 2026, totaling $43.2M in net buying, while two managers…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

S Feb 26 to Mar 3 2 days of insider sells: $17.3M by 2 insiders, avg $656.52
R May 5 IDEXX reported Q1 2026 revenue of $1.141B (+14% YoY) and GAAP EPS of…
I Jun 30 4 funds open new positions (13F)
R Aug 4 IDEXX reported Q2 2026 EPS of $4.27, an 8.5% beat vs consensus of $3…
S Sep 4 1 insider sell $1.2M at $532.08
A Oct 12 Keybanc initiates

Signal stack

Where each data set points today.

InsidersBEARISH

3 insiders sold $18.4M.
InstitutionsMIXED

Q2 2026: 52 added (4 new), 38 trimmed or exited. Largest new: Baillie Gifford & $186.3M, Massachusetts Financial Services /Ma/ $179.7M.
AnalystsBULLISH

14 of 21 rate it Buy or better.
Short sellersSTEADY

Short interest −0.6% to 1.93M shares. 3.6 days to cover, ≈2.5% of shares.
TrendUPTREND

5% above its 50-day average.

Who's buying

13F· Q2 2026

new positions

exit

$450.7M

in new stakes

Fund	Move	Shares	Value
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	ADD	1,067,078	$561.8M
Fundsmith LLP	TRIM	1,019,887	$536.9M
FMR LLC	DOUBLED	822,643	$433.1M
AMERICAN CENTURY COMPANIES INC	ADD	808,358	$425.6M
PRICE T ROWE ASSOCIATES INC /MD/	TRIM	458,318	$241.3M
Alyeska Investment Group, L.P.	ADD	401,082	$211.1M
NORGES BANK	TRIM	353,944	$186.3M
BAILLIE GIFFORD & CO	NEW	353,797	$186.3M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

21 analysts

Buy 67% rate it Buy or better

Strong Buy7Buy7Hold7Sell0Strong Sell0

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access

Recent actions

Date	Firm	Action	Rating
Oct 27, 2026	🔒 Fresh data, subscribers only MAINTAIN	MAINTAIN
Oct 16, 2026	JP Morgan MAINTAIN	MAINTAIN	Overweight
Oct 12, 2026	Keybanc INITIATE	INITIATE	Sector Weight
Aug 11, 2026	Barclays MAINTAIN	MAINTAIN	Overweight
Aug 5, 2026	UBS MAINTAIN	MAINTAIN	Neutral
Aug 5, 2026	Citigroup MAINTAIN	MAINTAIN	Neutral

Insider ledger

Form 4

bought · 0 insiders

$18.4M

sold · 3 insiders

Date	Insider	Type	Value
Sep 4, 2026	Kingsley Lawrence D Director	EXERCISE	$251.5K
Sep 4, 2026	Kingsley Lawrence D Director	SELL	$1.2M
Aug 20, 2026	Emerson Andrew EVP, CFO and Treasurer	TAX W/H	86 sh
Aug 20, 2026	Emerson Andrew EVP, CFO and Treasurer	EXERCISE	$47.2K
Jul 30, 2026	HOOLEY JOSEPH L Director	AWARD	$27.4K
Jun 1, 2026	FENNELL GEORGE Executive Vice President	TAX W/H	$161.0K
Jun 1, 2026	FENNELL GEORGE Executive Vice President	EXERCISE	639 sh
May 12, 2026	Kingsley Lawrence D Director	AWARD	75 sh

Earnings setup

Estimates

Nov 2

reports in 6 days

Revision history: 🔒 Fresh data, subscribers only

Period	EPS est.	Range	30D rev.	Revenue
Current Q	🔒 Fresh data, subscribers only
Next Q	🔒 Fresh data, subscribers only
Current FY	🔒 Fresh data, subscribers only
Next FY	🔒 Fresh data, subscribers only

Congressional trades

IDXX trades disclosed by members of Congress, with disclosure delay.

1 members · 3 buys / 4 sells

DateMemberType AmountDisclosed

Sep 25, 2026 Ro KhannaDHouse Spouse account · IDEXX Laboratories Inc BUY $1K–$15K Oct 7, 2026 +12d

Sep 11, 2026 Ro KhannaDHouse Child account · IDEXX Laboratories Inc SELL $15K–$50K Oct 7, 2026 +26d

Sep 4, 2026 Ro KhannaDHouse Spouse account · IDEXX Laboratories Inc SELL $1K–$15K Oct 7, 2026 +33d

May 27, 2026 Ro KhannaDHouse Spouse account · IDEXX Laboratories Inc BUY $1K–$15K Jun 9, 2026 +13d

May 15, 2026 Ro KhannaDHouse Spouse account · IDEXX Laboratories Inc SELL $1K–$15K Jun 9, 2026 +25d

May 1, 2026 Ro KhannaDHouse Child account · IDEXX Laboratories Inc SELL $1K–$15K Jun 9, 2026 +39d

Apr 13, 2026 Ro KhannaDHouse Spouse account · IDEXX Laboratories Inc BUY $1K–$15K May 11, 2026 +28d

Short side

FINRA· Oct 15, 2026

1,929,268

shares short

-0.6%

vs prior settlement

3.6

days to cover

≈2.5%

of shares outstanding

Recent activity

The latest filings, insider trades, analyst actions, press and options flow — newest first.

Oct 26, 2026 SEC

Three asset managers added to IDXX positions in Q3 2026, totaling $43.2M in net buying, while two managers trimmed…

INST-CLUSTER — Impact 3/10

Oct 16, 2026 SEC

The court granted IDEXX's motion to set aside an entry of default in a former employee's disability discrimination…

COURT-RULING — Impact 2/10

Oct 16, 2026 Event

McClain v. IDEXX Laboratories, Inc.

Court ruling (mdd) — Docket: 1:26-cv-01090

Sep 25, 2026 Congress

Ro Khanna buy

$1,001 - $15,000 — House

Sep 11, 2026 Congress

Ro Khanna sell

$15,001 - $50,000 — House

Sep 4, 2026 Insider

Kingsley Lawrence D acquired via exercise 2,203 shares

Director @ $114.17 ($251.5K)

Sep 4, 2026 Insider

Kingsley Lawrence D sold 2,203 shares

Director @ $532.08 ($1.2M)

Aug 20, 2026 Insider

Emerson Andrew surrendered for taxes 86 shares

EVP, CFO and Treasurer

Catalysts

Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.

Upcoming

Nov 2, 2026

Earnings date

IDXX Q3 2026 Earnings Before Market Open — 2026-11-02

Recent

Oct 16, 2026

Enforcement

McClain v. IDEXX Laboratories, Inc.

Court ruling (mdd) — Docket: 1:26-cv-01090

Aug 4, 2026

Earnings date

IDXX Q2 2026 Earnings Before Market Open — 2026-08-04

May 12, 2026

Short interest

FTD: IDXX — 3,957 shares ($2.1M) failed to deliver

Settlement: 20260512, Price: $532.00, FTD Value: $2,105,124, IDEXX LABORATORIES CORP

May 5, 2026

Earnings date

IDXX Q1 2026 Earnings Before Market Open — 2026-05-05

Apr 24, 2026

Short interest

FTD: IDXX — 13,026 shares ($7.3M) failed to deliver

Settlement: 20260424, Price: $560.93, FTD Value: $7,306,674.18, IDEXX LABORATORIES CORP

SecBot reports

5 filings · 2 bullish · 0 bearish · 3 neutral

All IDXX filing & press-release reports (5)

INST-CLUSTER reportOct 26, 2026
COURT-RULING reportOct 16, 2026
8-K reportAug 4, 2026
8-K reportMay 5, 2026
DEFA14A reportMar 27, 2026